Abstract #3548

T1- MRI Assessment of Hepatobiliary Fibrosis in Cystic Fibrosis Patients: Significance for Chronic Liver Diseases

Shannon Donnola¹, Kimberly McBennett^2,3, David Weaver³, Lan Lu^1,4, Xin Yu^1,5,6, James Chmiel³, Michael Konstan³, Mitchell Drumm^3,7, and Chris Flask^1,3,5

¹Radiology, Case Western Reserve University, Cleveland, OH, United States, ²Medicine, University Hospitals of Cleveland, OH, United States, ³Pediatrics, University Hospitals of Cleveland, Cleveland, OH, United States, ⁴Urology, Case Western Reserve University, Cleveland, OH, United States, ⁵Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States, ⁶Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, United States, ⁷Genetics, Case Western Reserve University, Cleveland, OH, United States

Liver disease is the third leading cause of death in Cystic Fibrosis (CF). Unfortunately, conventional liver function tests cannot sensitively detect it.^1-3Liver stiffness measurements via MRI and ultrasound have shown promise but are unfortunately impacted by other factors (e.g., hepatic fat) potentially resulting in over-estimation of fibrosis.^4,5 We recently validated a T1-MRI assessment of biliary dilatation and fibrosis in a rat model of congenital hepatic fibrosis (Figs. 1-3).⁶ In this clinical study, we show that T1-MRI can be used to sensitively detect increased percent bile duct volumes in CF patients in comparison to control subjects with normal liver function.

This abstract and the presentation materials are available to members only; a login is required.

Join Here